Febuxostat Impurity 3 | CAS 1330632-47-7 - Request Quote
Febuxostat Impurity 3
| SZ CAT No: | SZ-F010024 |
| CAS No | 1330632-47-7 |
| Mol.F. | C22H24N2O5S2 |
| Mol.Wt. | 460.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Febuxostat Impurity 3 is chemically (Dimethyl 2,2'-(4-isobutoxy-1,3-phenylene)bis(4-methylthiazole-5-carboxylate)). Febuxostat Impurity 3 is supplied with detailed characterization data compliant with regulatory guideline. Febuxostat Impurity 3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Febuxostat.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1330632-47-7
Purchase 1330632-47-7
Order 1330632-47-7
Enquire 1330632-47-7
price of 1330632-47-7
1330632-47-7 Supplier
1330632-47-7 Manufacturer
1330632-47-7 Exporter
buy high quality Febuxostat Impurity 3
Purchase Febuxostat Impurity 3
Febuxostat Impurity 3 suppliers
Febuxostat Impurity 3 manufacturers
Febuxostat Impurity 3 price
Order Febuxostat Impurity 3
Enquire Febuxostat Impurity 3
Febuxostat Impurity 3 cost
Febuxostat Impurity 3 Supplier
Febuxostat Impurity 3 Distributor
Febuxostat Impurity 3 for Method Validation
Febuxostat Reference Standard
Febuxostat Impurity 3 for ANDA Filing
Febuxostat Impurity 3 for Forced Degradation Studies
Febuxostat Impurity 3 Identification Standards
Febuxostat Impurity 3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.